These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 12828157)

  • 1. Topical treatment of persistent cutaneous leishmaniasis with ethanolic lipid amphotericin B.
    Zvulunov A; Cagnano E; Frankenburg S; Barenholz Y; Vardy D
    Pediatr Infect Dis J; 2003 Jun; 22(6):567-9. PubMed ID: 12828157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liposomal amphotericin B in comparison to sodium stibogluconate for cutaneous infection due to Leishmania braziliensis.
    Solomon M; Baum S; Barzilai A; Scope A; Trau H; Schwartz E
    J Am Acad Dermatol; 2007 Apr; 56(4):612-6. PubMed ID: 17276541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous leishmaniasis: successful treatment with itraconazole.
    Consigli J; Danielo C; Gallerano V; Papa M; Guidi A
    Int J Dermatol; 2006 Jan; 45(1):46-9. PubMed ID: 16426375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of cutaneous leishmaniasis by intralesional metronidazole.
    Al-Waiz M; Sharquie KE; Al-Assir M
    Saudi Med J; 2004 Oct; 25(10):1512-3. PubMed ID: 15494841
    [No Abstract]   [Full Text] [Related]  

  • 5. [Cutaneous leishmaniasis treated with ambisome (liposomal amphotericin B)].
    Ben-Shimol S; Sagi O; Schwartz E; Greenberg D
    Harefuah; 2012 Aug; 151(8):458-60, 498. PubMed ID: 23350289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical Amphotericin B for the treatment of localized cutaneous leishmaniasis.
    Alcántara-Reifs CM; Garnacho-Saucedo G; Salido-Vallejo R; Vélez García-Nieto A
    Dermatol Ther; 2017 Jan; 30(1):. PubMed ID: 27636906
    [No Abstract]   [Full Text] [Related]  

  • 7. Successful liposomal amphotericin B treatment of Leishmania braziliensis cutaneous leishmaniasis.
    Brown M; Noursadeghi M; Boyle J; Davidson RN
    Br J Dermatol; 2005 Jul; 153(1):203-5. PubMed ID: 16029352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of cutaneous leishmaniasis with lipid formulations of amphotericin B in two immunocompromised patients.
    Amato VS; Rabello A; Rotondo-Silva A; Kono A; Maldonado TP; Alves IC; Floeter-Winter LM; Neto VA; Shikanai-Yasuda MA
    Acta Trop; 2004 Oct; 92(2):127-32. PubMed ID: 15350864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leishmania tropica in children: a retrospective study.
    Solomon M; Schwartz E; Pavlotsky F; Sakka N; Barzilai A; Greenberger S
    J Am Acad Dermatol; 2014 Aug; 71(2):271-7. PubMed ID: 24775403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison between the efficacy of photodynamic therapy and topical paromomycin in the treatment of Old World cutaneous leishmaniasis: a placebo-controlled, randomized clinical trial.
    Asilian A; Davami M
    Clin Exp Dermatol; 2006 Sep; 31(5):634-7. PubMed ID: 16780497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical calcipotriol ointment in the treatment of morphea.
    Tay YK
    J Dermatolog Treat; 2003 Dec; 14(4):219-21. PubMed ID: 14660267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Leishmania braziliensis: report of a pediatric imported case with response to liposomal amphotericin B].
    Campos-Muñoz L; Quesada-Cortés A; Martín-Díaz MA; Rubio-Flores C; de Lucas-Laguna R
    Actas Dermosifiliogr; 2007; 98(1):42-4. PubMed ID: 17374332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Old world Leishmania infantum cutaneous leishmaniasis unresponsive to liposomal amphotericin B treated with topical imiquimod.
    Hervás JA; Martín-Santiago A; Hervás D; Rojo E; Mena A; Rocamora V; Dueñas J
    Pediatr Infect Dis J; 2012 Jan; 31(1):97-100. PubMed ID: 21829140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of intralesional 0.2% ciprofloxacin as a treatment for cutaneous leishmaniasis.
    Al Hamdi K; Awad AH; Moker HM
    East Mediterr Health J; 2010 Jan; 16(1):89-93. PubMed ID: 20214164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the effectiveness of two topical paromomycin treatments versus meglumine antimoniate for New World cutaneous leishmaniasis.
    Armijos RX; Weigel MM; Calvopiña M; Mancheno M; Rodriguez R
    Acta Trop; 2004 Jul; 91(2):153-60. PubMed ID: 15234664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of old world cutaneous leishmaniasis in refugee children.
    Crogan J; Gunasekera H; Wood N; Sheikh M; Isaacs D
    Pediatr Infect Dis J; 2010 Apr; 29(4):357-9. PubMed ID: 19952859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative study between the efficacy of systemic meglumine antimoniate therapy with standard or low dose plus oral omeprazole in the treatment of cutaneous leishmaniasis.
    Nilforoushzadeh MA; Jaffary F; Ansari N; Siadat AH; Nilforoushan Z; Firouz A
    J Vector Borne Dis; 2008 Dec; 45(4):287-91. PubMed ID: 19248655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of treatment with pentamidine for cutaneous leishmaniasis in Suriname.
    van der Meide WF; Sabajo LO; Jensema AJ; Peekel I; Faber WR; Schallig HD; Fat RF
    Int J Dermatol; 2009 Jan; 48(1):52-8. PubMed ID: 19126051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacious topical treatment for human cutaneous leishmaniasis with ethanolic lipid amphotericin B.
    Vardy D; Barenholz Y; Naftoliev N; Klaus S; Gilead L; Frankenburg S
    Trans R Soc Trop Med Hyg; 2001; 95(2):184-6. PubMed ID: 11355557
    [No Abstract]   [Full Text] [Related]  

  • 20. Topical tacrolimus and the 308-nm excimer laser: a synergistic combination for the treatment of vitiligo.
    Passeron T; Ostovari N; Zakaria W; Fontas E; Larrouy JC; Lacour JP; Ortonne JP
    Arch Dermatol; 2004 Sep; 140(9):1065-9. PubMed ID: 15381545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.